Vol. 36.Issue. 4. July - August 2017 | Revista Española de Medicina Nuclear e Imagen Molecular (English Edition)

ISSN: 2253-8089

The Revista Española de Medicina Nuclear e Imagen Molecular (Spanish Journal of Nuclear Medicine and Molecular Imaging), was founded in 1982, and is the official journal of the Spanish Society of Nuclear Medicine and Molecular Imaging, which has more than 700 members. The Journal, which publishes 6 regular issues per year, has the promotion of research and continuing education in all fields of Nuclear Medicine as its main aim. For this, its principal sections are Originals, Clinical Notes, Images of Interest, and Special Collaboration articles. The works may be submitted in Spanish or English and are subjected to a peer review process. In 2009, it became the leading Spanish journal in the field of Medical Imaging on having an Impact Factor , awarded by the Journal Citation Reports.

See more Open Access Option

Indexed in:

Science Citation Index Expander, Medline, IME, Bibliomed, EMBASE/Excerpta Medica, Healthstar, Cancerlit, Toxine, Inside Conferences, Scopus

Subscribe:

Impact factor

The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years.

© Clarivate Analytics, Journal Citation Reports 2022

Impact factor 2022

1.2

Citescore

CiteScore measures average citations received per document published.

Citescore 2022

1.2

SJR

SRJ is a prestige metric based on the idea that not all citations are the same. SJR uses a similar algorithm as the Google page rank; it provides a quantitative and qualitative measure of the journal's impact.

SJR 2022

0.254

SNIP

SNIP measures contextual citation impact by wighting citations based on the total number of citations in a subject field.

SNIP 2022

0.414

View more metrics

Journal Information

Previous Issue | Next Issue

Issue

Vol. 36. Issue 4.

Pages 205-272 (July - August 2017)

Original articles

Comparison of 99mTc-MDP SPECT qualitative vs quantitative results in patients with suspected condylar hyperplasia

D.F. López Buitrago, J. Ruiz Botero, C.M. Corral, A.R. Carmona, A. Sabogal

Rev Esp Med Nucl Imagen Mol. 2017;36:207-11

Influence of previous breast surgery in sentinel lymph node biopsy in patients with breast cancer

V. López-Prior, R. Díaz-Expósito, I. Casáns Tormo

Rev Esp Med Nucl Imagen Mol. 2017;36:212-8

A new era for Nuclear Medicine neuroimaging in Spain: Where do we start from?

M.A. Balsa, V. Camacho, P. Garrastachu, D. García-Solís, M. Gómez-Río, S. Rubí, X. Setoain, J. Arbizu

Rev Esp Med Nucl Imagen Mol. 2017;36:219-26

The usefulness of 18F-fluorocholine PET/CT in the detection of recurrence of central nervous system primary neoplasms

A. Montes, A. Fernández, V. Camacho, C. de Quintana, O. Gallego, J. Craven-Bartle, D. López, J. Molet, ... I. Carrió

Rev Esp Med Nucl Imagen Mol. 2017;36:227-32

18F-FDG PET/CT as predictor of tumor biology and prognosis in epithelial ovarian carcinoma

B. González García, A.M. García Vicente, G.A. Jiménez Londoño, F.J. Pena Pardo, M.E. Bellón Guardia, M.P. Talavera Rubio, A. Palomar Muñoz, P. Gómez Herrero, Á.M. Soriano Castrejón

Rev Esp Med Nucl Imagen Mol. 2017;36:233-40

Role of 18F-Choline PET/CT in guiding biopsy in patients with risen PSA levels and previous negative biopsy for prostate cancer

G.A. Jiménez Londoño, A.M. García Vicente, M. Amo-Salas, F. Fúnez Mayorga, M.A. López Guerrero, M.P. Talavera Rubio, P. Gutierrez Martin, B. González García, ... Á.M. Soriano Castrejón

Rev Esp Med Nucl Imagen Mol. 2017;36:241-6